These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 16201903

  • 1. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients.
    Cavalier E, Delanaye P, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2005; 43(8):890-1. PubMed ID: 16201903
    [No Abstract] [Full Text] [Related]

  • 2. Analytical validation of the new version of the Liaison N-Tact PTH assay.
    Cavalier E, Delanaye P, Carlisi A, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2007; 45(1):105-7. PubMed ID: 17243925
    [Abstract] [Full Text] [Related]

  • 3. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 4. [Whole-PTH assay--new method for assessment of parathyroid function].
    Nishi H, Nakanishi S, Fukagawa M.
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():569-73. PubMed ID: 15250371
    [No Abstract] [Full Text] [Related]

  • 5. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E, Salsé M, Dupuy AM, Bargnoux AS, Watar F, Souberbielle JC, Delanaye P, Cristol JP.
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [Abstract] [Full Text] [Related]

  • 6. Direct comparison between two 1-84PTH assays in dialysis patients.
    Kazama JJ, Yamamoto S, Kameda S, Maruyama H, Narita I, Shigematsu T, Gejyo F.
    Nephron Clin Pract; 2005 Apr; 99(1):c8-12. PubMed ID: 15637461
    [Abstract] [Full Text] [Related]

  • 7. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
    Cantor T, Yang Z, Caraiani N, Ilamathi E.
    Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070
    [Abstract] [Full Text] [Related]

  • 8. Concurrent evaluation of PTH in hemodialysis patients using N-tact-IRMA and third generation Liaison 1-84 PTH (DiaSorin).
    Benchetrit S, Green J, Bernheim J, Golan E, Zitman-Gal T.
    Clin Biochem; 2013 Mar; 46(4-5):395-6. PubMed ID: 23262403
    [No Abstract] [Full Text] [Related]

  • 9. The need for reliable serum parathyroid hormone measurements.
    Torres PU.
    Kidney Int; 2006 Jul; 70(2):240-3. PubMed ID: 16838038
    [Abstract] [Full Text] [Related]

  • 10. Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.
    Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():56-61. PubMed ID: 21595854
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the intact PTH test with the total PTH test in hemodialyzed patients].
    Pecovnik Balon B, Puklavec L, Hojs R.
    Acta Med Croatica; 2003 Jun; 57(1):69-70. PubMed ID: 12876868
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.
    Aubry WM, Sparks JC, Braunstein GD.
    Mt Sinai J Med; 1984 Apr; 51(2):132-7. PubMed ID: 6610110
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
    John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
    [Abstract] [Full Text] [Related]

  • 15. Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.
    Schleck ML, Souberbielle JC, Delanaye P, Plebani M, Cavalier E.
    Clin Chem Lab Med; 2017 Jul 26; 55(8):1152-1159. PubMed ID: 28099122
    [Abstract] [Full Text] [Related]

  • 16. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H.
    Clin Nephrol; 1992 Sep 26; 38(3):154-7. PubMed ID: 1395169
    [Abstract] [Full Text] [Related]

  • 17. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
    Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP.
    J Clin Endocrinol Metab; 2003 Oct 26; 88(10):4725-30. PubMed ID: 14557447
    [Abstract] [Full Text] [Related]

  • 18. PTH determination in hemodialyzed patients-A laboratory perspective.
    Cavalier E, Souberbielle JC, Delanaye P.
    Semin Dial; 2019 Nov 26; 32(6):490-492. PubMed ID: 31631422
    [Abstract] [Full Text] [Related]

  • 19. The evolution of assays for parathyroid hormone.
    Goodman WG.
    Semin Dial; 2005 Nov 26; 18(4):296-301. PubMed ID: 16076352
    [Abstract] [Full Text] [Related]

  • 20. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D.
    G Ital Nefrol; 2002 Nov 26; 19(4):467-75. PubMed ID: 12369051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.